ARTA
EPZM

A.R.T. Advisors’s Epizyme, Inc EPZM Stock Holding History

A.R.T. Advisors’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-89,139
Closed -$919K – 1851
2019
Q3 		$919K Buy
89,139
+62,900
+240% +$793K 0.05% 589
2019
Q2 		$329K Sell
26,239
-93,100
-78% -$1.2M 0.02% 913
2019
Q1 		$1.48M Buy
+119,339
New +$1.33M 0.09% 335
2018
Q3 		– Sell
-66,924
Closed -$906K – 1818
2018
Q2 		$906K Buy
66,924
+19,895
+42% +$310K 0.04% 676
2018
Q1 		$834K Buy
+47,029
New +$794K 0.03% 731
2017
Q3 		– Sell
-12,489
Closed -$188K – 1775
2017
Q2 		$188K Buy
+12,489
New +$189K 0.01% 1174
2015
Q1 		– Sell
-56,440
Closed -$1.06M – 1776
2014
Q4 		$1.06M Buy
56,440
+40,591
+256% +$948K 0.04% 621
2014
Q3 		$429K Buy
+15,849
New +$493K 0.02% 813
2014
Q1 		– Sell
-58,626
Closed -$1.22M – 1625
2013
Q4 		$1.22M Buy
+58,626
New +$1.7M 0.06% 409

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

A.R.T. Advisors's EPZM Position: Q4 2019 in Review

A.R.T. Advisors sold out of Epizyme, Inc (EPZM) in Q4 2019, closing a stake of 89,139 shares — an estimated $919K sold.

A.R.T. Advisors first reported a position in EPZM in Q4 2013 and held it in 9 quarters. The position peaked at $1.48M in Q1 2019. 136 funds tracked by Wall St. Rank hold EPZM as of Q4 2019.

  • A.R.T. Advisors reported no remaining Epizyme, Inc position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 89,139 Epizyme, Inc shares in Q4 2019, an estimated $919K.
  • A.R.T. Advisors first reported a position in Epizyme, Inc in Q4 2013 and held it in 9 quarters.
  • A.R.T. Advisors's Epizyme, Inc position peaked at $1.48M in Q1 2019.
  • 136 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.